Perspectives and challenges in regenerative medicine using plasma rich in growth factors

被引：163

作者：

Anitua, Eduardo ^{[1
]}

Alkhraisat, Mohammad H. ^{[1
]}

Orive, Gorka ^{[1
]}

机构：

[1] BTI Biotechnol Inst, Vitoria, Spain

来源：

JOURNAL OF CONTROLLED RELEASE | 2012年 / 157卷 / 01期

关键词：

Plasma rich in growth factors; Fibrin; Autologous; Growth factors; Tissue regeneration; ENDOTHELIAL PROGENITOR CELLS; IN-VITRO; PERIODONTAL-LIGAMENT; DENTAL IMPLANTS; CROSS-LINKING; STEM-CELLS; MECHANICAL-PROPERTIES; ELECTRON-MICROSCOPE; TISSUE REGENERATION; STRESS-RELAXATION;

D O I：

10.1016/j.jconrel.2011.07.004

中图分类号：

O6 [化学];

学科分类号：

070301 [无机化学];

摘要：

Plasma rich in growth factors (PRGF-Endoret) is an endogenous therapeutic technology that is gaining interest in regenerative medicine due to its potential to stimulate and accelerate tissue healing and bone regeneration. This autologous biotechnology is designed for the in situ delivery of multiple cellular modulators and the formation of a fibrin scaffold, thereby providing different formulations that can be widely used in numerous medical and scientific fields including dentistry, oral implantology, orthopedics, ulcer treatment and tissue engineering among others. Here we discuss the important progress that has been accomplished in this field. Furthermore, a comprehensive outlook of the intriguing therapeutic applications of this technology is presented. (C) 2011 Elsevier B. V. All rights reserved.

引用

页码：29 / 38

页数：10

共 136 条

[61]

Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33

[62]

Use of Fibrin Clot in the Knee [J].